Filing Flows › GeneDx Holdings (WGS) › Other revenue revenue
GeneDx Holdings (WGS) Other revenue revenue by quarter
GeneDx Holdings' Other revenue revenue was $2.6M in Q2 2026 (second quarter 2026), +167% from Q1 2026. Over the last 7 quarters it ranged from $955K (Q1 2026) to $3.7M (Q4 2025).
| Quarter | Other revenue revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $2.6M | +167% | -11% |
| Q1 2026 | $955K | -74% | -30% |
| Q4 2025 | $3.7M | +15% | +156% |
| Q3 2025 | $3.2M | +12% | — |
| Q2 2025 | $2.9M | +112% | — |
| Q1 2025 | $1.4M | -6% | — |
| Q4 2024 | $1.4M | — | — |
Q2 2026 at a glance
GeneDx Holdings, Q2 2026: revenue $114M (+11% year over year), operating margin -15.3%, net loss $17.7M, operating cash flow −$29.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is GeneDx Holdings' Other revenue revenue?
GeneDx Holdings' Other revenue revenue was $2.6M in Q2 2026 (second quarter 2026), +167% from Q1 2026.
How has GeneDx Holdings' Other revenue revenue changed?
Over the last 7 quarters it ranged from $955K (Q1 2026) to $3.7M (Q4 2025).